CN1425396A - Herbal medicine blood sugar reducing powder or tablet - Google Patents
Herbal medicine blood sugar reducing powder or tablet Download PDFInfo
- Publication number
- CN1425396A CN1425396A CN 01138813 CN01138813A CN1425396A CN 1425396 A CN1425396 A CN 1425396A CN 01138813 CN01138813 CN 01138813 CN 01138813 A CN01138813 A CN 01138813A CN 1425396 A CN1425396 A CN 1425396A
- Authority
- CN
- China
- Prior art keywords
- radix
- blood sugar
- sugar reducing
- herbal medicine
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The Chinese medicine for treating diabetes and preventing relapse of diabetes consists of bigleaf ginseng, astragalus root, red sage, rhinoceros horn, tortoise, plastron, human placenta and bear bile. The Chinese medicine is used in the treatment of diabetes of I, II and III stage, and has high curative effect and effective rate.
Description
Technical field: a kind ofly treat diabetes, prevent that the traditional Chinese medicine mouth of diabetes class patient and feelings bounce-back from taking medicine.
Background technology: present existing Remedies for diabetes mostly is greatly and takes stopgap measures, and more intense dependency is arranged, and need take medicine throughout one's life in case fall ill, and the state of an illness can only be controlled often repeatedly, is difficult to cure.
Summary of the invention:
The problem to be solved in the present invention is: the traditional Chinese medicine mouth of provide a kind for the treatment of both the principal and secondary aspects of a disease, effectively controlling the treatment diabetes of bounce-back is taken medicine.
The scheme that the present invention solves the problems of the technologies described above is:
Herbal medicine blood sugar reducing powder or sheet, its Chinese medicine comprises Da Ye Radix Ginseng, the Radix Astragali, Radix Salviae Miltiorrhizae, Cornu rhinocerotis, Carapax et Plastrum Testudinis, Placenta Hominis, Fel Ursi in forming.
The weight proportion of above-mentioned Chinese medicine is: Da Ye Radix Ginseng 50-100: Radix Astragali 50-100: Radix Salviae Miltiorrhizae 50-100: Cornu rhinocerotis 30-50: Carapax et Plastrum Testudinis 50-100: 1 of Placenta Hominis 3 tools, Fel Ursi.
Above-mentioned herbal medicine blood sugar reducing powder or sheet, described Chinese medicine also comprise Rhizoma Dioscoreae, Cortex Lycii, Fructus Schisandrae Chinensis, a kind of in Radix Ophiopogonis or several, and its weight proportion is: Rhizoma Dioscoreae 50-100, Cortex Lycii 50-100, Fructus Schisandrae Chinensis 50-100, Radix Ophiopogonis 50-100.
Above-mentioned herbal medicine blood sugar reducing powder or sheet, described Chinese medicine also comprises: Semen Fagopyri Esculenti 50-100, Radix Angelicae Sinensis 50-100, Radix Rehmanniae 50-100, Radix Glycyrrhizae 10-50, Rhizoma Anemarrhenae 50-100, Rhizoma Corydalis 90-120, Fel Sus domestica or Fel Canitis or Fel Caprae seu Ovis 10-15 only, optional wherein a kind of of Radix Puerariae 50-100, Moschus 5-10 or several.
The present invention with the beneficial effect that existing technology is compared is:
1. according to group experiment, use the patient of this product that 95% above significant effective is arranged, cure rate does not rebound after the drug withdrawal more than 65%.
2. carry out the monarch drug that is arranged to form of basic equivalent in this product by Chinese medicines such as Radix Ginseng, the Radix Astragali, the Radix Rehmanniae, the Rhizoma Anemarrhenae, Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Radix Puerariae, Rhizoma Dioscoreae, Cortex Lycii, Fructus Schisandrae Chinensis, Carapax et Plastrum Testudinis, Placenta Hominis, Radix Ophiopogonis, Fel Ursi, Cornu rhinocerotiss, the mutual note of medicine behind the compatibility has heat clearing away, blood-enriching qi-invigorating, removing heat from blood promote the production of body fluid, the quench the thirst effect of effecting a permanent cure of blood sugar lowering.
3. adopt in this product that Folium Epimedii, Semen Persicae, Rhizoma Alismatis, the Rhizoma Atractylodis Macrocephalae, Flos Lonicerae, Fructus Corni, Fructus Lycii, benefit bone refer to, a kind of in the Radix Angelicae Sinensis, Semen Cuscutae, Radix Trichosanthis etc. or several constitute ministerial drugs, play the effect that auxiliary monarch drug is strengthened the monarch drug curative effect.
4. can adopt a kind of or several Chinese medicines in Semen Fagopyri Esculenti, Semen Coicis, Fructus Litchi, the pollen in this product is that auxiliary monarch drug of adjuvant drug and ministerial drug carry out comprehensive treatment.
5. can adopt Radix Glycyrrhizae, Herba Taraxaci, Herba Violae, Fel Sus domestica, Fel Caprae seu Ovis, Fel Canitis as messenger drug in this product, can promote the through sufferer place of medicine of monarch drug and ministerial drug, adjuvant drug significantly.
6. above medicine calculates with gram, grinding is mixed and obeys the 5-50 gram back every day, can determine dose according to the content of monarch drug wherein, general blood glucose 13, glucose in urine +++patient's (I type), a treatment in month finishes blood glucose 18, glucose in urine ++ ++ patient's (II type), general one month course of treatment, two course of therapy finish, and the patient of the above diabetes of III type finishes treatment general three courses of treatment.
Embodiment 1:
Herbal medicine blood sugar reducing powder or sheet, its Chinese medicine comprises Da Ye Radix Ginseng, the Radix Astragali, Radix Salviae Miltiorrhizae, Cornu rhinocerotis, Carapax et Plastrum Testudinis, Placenta Hominis, Fel Ursi in forming, can equivalent adding also can be according to the adjustment of the comprehensive variation amount of carrying out of area and morbidity colony.
Embodiment 2:
Above-mentioned herbal medicine blood sugar reducing powder or sheet, the weight proportion of described Chinese medicine is: Da Ye Radix Ginseng 50g, 75g or 100g, Radix Astragali 50g, 75g or 100g, Radix Salviae Miltiorrhizae 50g, 75g or 100g, Cornu rhinocerotis 30g, 40g or 50g, Carapax et Plastrum Testudinis 50g, 75g or 100g, 1 of Placenta Hominis 3 tools, Fel Ursi.
Embodiment 3:
Above-mentioned herbal medicine blood sugar reducing powder or sheet, described Chinese medicine also comprises Rhizoma Dioscoreae, Cortex Lycii, Fructus Schisandrae Chinensis, a kind of in Radix Ophiopogonis or several, and its weight proportion is: Rhizoma Dioscoreae 50g, 75g or 100g, Cortex Lycii 50g, 75g or 100g, Fructus Schisandrae Chinensis 50g, 75g or 100g, Radix Ophiopogonis 50g, 75g or 100g.
Embodiment 4:
Above-mentioned herbal medicine blood sugar reducing powder or sheet, described Chinese medicine also comprises: Semen Fagopyri Esculenti 50-100g, Radix Angelicae Sinensis 50-100g, Radix Rehmanniae 50-100g, Radix Glycyrrhizae 10-50g, Rhizoma Anemarrhenae 50-100g, Rhizoma Corydalis 90-120g, Fel Sus domestica or Fel Canitis or Fel Caprae seu Ovis 10-15 only, a kind of among Radix Puerariae 50-100, the Moschus 5-10 or several.
Auxiliary
Claims (4)
1. herbal medicine blood sugar reducing powder or sheet, it is characterized in that: its Chinese medicine comprises Da Ye Radix Ginseng, the Radix Astragali, Radix Salviae Miltiorrhizae, Cornu rhinocerotis, Carapax et Plastrum Testudinis, Placenta Hominis, Fel Ursi in forming.
2. herbal medicine blood sugar reducing powder according to claim 1 or sheet is characterized in that: the weight proportion of described Chinese medicine is: Da Ye Radix Ginseng 50-100: Radix Astragali 50-100: Radix Salviae Miltiorrhizae 50-100: Cornu rhinocerotis 30-50: Carapax et Plastrum Testudinis 50-100: 1 of Placenta Hominis 3 tools, Fel Ursi.
3. herbal medicine blood sugar reducing powder according to claim 1 and 2 or sheet, it is characterized in that: described Chinese medicine also comprises Rhizoma Dioscoreae, Cortex Lycii, Fructus Schisandrae Chinensis, a kind of in Radix Ophiopogonis or several, and its weight proportion is: Rhizoma Dioscoreae 50-100, Cortex Lycii 50-100, Fructus Schisandrae Chinensis 50-100, Radix Ophiopogonis 50-100.
4. herbal medicine blood sugar reducing powder according to claim 1 and 2 or sheet is characterized in that: described Chinese medicine also comprises: Semen Fagopyri Esculenti 50-100, Radix Angelicae Sinensis 50-100, Radix Rehmanniae 50-100, Radix Glycyrrhizae 10-50, Rhizoma Anemarrhenae 50-100, Rhizoma Corydalis 90-120, Fel Sus domestica or Fel Canitis or Fel Caprae seu Ovis 10-15 only, a kind of among Radix Puerariae 50-100, the Moschus 5-10 or several.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01138813 CN1425396A (en) | 2001-12-10 | 2001-12-10 | Herbal medicine blood sugar reducing powder or tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01138813 CN1425396A (en) | 2001-12-10 | 2001-12-10 | Herbal medicine blood sugar reducing powder or tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1425396A true CN1425396A (en) | 2003-06-25 |
Family
ID=4674775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01138813 Pending CN1425396A (en) | 2001-12-10 | 2001-12-10 | Herbal medicine blood sugar reducing powder or tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1425396A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102065874B (en) * | 2008-06-12 | 2013-02-13 | 陈思成 | Compositions for reducing blood glucose level and uses thereof |
| CN104367631A (en) * | 2014-11-13 | 2015-02-25 | 成都医路康医学技术服务有限公司 | Traditional Chinese medicine composition containing tortoise plastron and used for treating diabetic foot |
-
2001
- 2001-12-10 CN CN 01138813 patent/CN1425396A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102065874B (en) * | 2008-06-12 | 2013-02-13 | 陈思成 | Compositions for reducing blood glucose level and uses thereof |
| CN104367631A (en) * | 2014-11-13 | 2015-02-25 | 成都医路康医学技术服务有限公司 | Traditional Chinese medicine composition containing tortoise plastron and used for treating diabetic foot |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN1120010C (en) | Scrophularia capsule and its preparing process | |
| CA3219450A1 (en) | Traditional chinese medicine composition for infectious disease recovery and use thereof | |
| CN1131053C (en) | Chinese medicine for treating diabetes | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN1159037C (en) | Medicine for treating apoplexy | |
| CN1425396A (en) | Herbal medicine blood sugar reducing powder or tablet | |
| CN1336212A (en) | Diabetes treating medicine | |
| CN1160560A (en) | Chinese patent drug for curing leukopenia and its preparation process | |
| CN1051462C (en) | "Yuanshen" pill-medicine for treatment of encephalatrophy | |
| CN1686227A (en) | Menstruation regulating powder | |
| CN1903302A (en) | Traditional Chinese medicine liquor for improving-Yang and treating diabete thristy disease | |
| CN102813733A (en) | Herb tea capable of resisting cancer, preventing diabetes mellitus and enhancing immunity | |
| CN1240415C (en) | Tablets against allergic purpura | |
| CN1069053C (en) | Oral medicine for treating phlegm-heat cough | |
| CN1063950C (en) | Brain reinforcing ointment | |
| CN101703645B (en) | Chinese medicinal composition for treating cervical vertebra hyperosteogeny | |
| CN1184978C (en) | Chinese medicine for treating diabetes and keto acid toxication | |
| CN101732423A (en) | Chinese medicinal pills for treating hepatosplenomegaly | |
| CN1245206C (en) | Traditional Chinese medicine for treating pancreatitis | |
| CN101991762A (en) | Traditional Chinese medicine for treating refractory asthma and preparation method thereof | |
| CN1108952A (en) | Xiaokelin capsule for diabetes | |
| CN1788776A (en) | Chinese traditional medicine for treating diabetes retinopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |